May 15th, 2008
FOR IMMEDIATE RELEASE
GE Healthcare to Distribute GeneBio’s Phenyx in Latin
America
Geneva, Switzerland, and São Paulo, Brazil – May 15, 2008 - Geneva
Bioinformatics (GeneBio) SA and GE Healthcare Life Sciences Latin America (GEHC-LS)
today announced a distribution agreement whereby GEHC-LS will distribute
GeneBio’s Phenyx MS identification platform throughout Latin America. This deal
builds upon the long lasting relationship between GE Healthcare and GeneBio
concerning the distribution of GeneBio’s Melanie imaging platform.
Under the terms of the agreement, GEHC-LS will distribute Phenyx within the
Latin American market as the exclusive MS software component of their impressive
product offerings. The deal encompasses GeneBio’s Phenyx (for MS-MS
identification), Aldente (for PMF analysis) as well as Phenyx’s Daemon and other
MS related software products that GeneBio will be putting on the market in the
future.
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB),
Phenyx is GeneBio’s renowned software platform for the identification and
characterization of proteins and peptides from mass spectrometry data,
specifically designed to meet the concurrent demands of high-throughput MS data
analysis and dynamic results assessment while offering a flexible user
experience and an adaptable architecture to help instil confidence in results
assessment. (http://phenyx.vital-it.ch/pwi)
“We fully believe in bringing quality products and companies to our distribution
network,” said Gyvair Molinari, Business Director of GE Healthcare Life
Sciences. “We have partnered with GeneBio for many years over Melanie and
ImageMaster. We know and trust GeneBio’s team, both the quality of the products
they develop and the scientific knowledge they possess. Their high level of
expertise and extensive client support lead us to believe that the Phenyx
platform will have an immediate impact on an expanded GEHC-LS offering in Latin
America. We look forward to continuing our relationship with GeneBio and to the
success of Phenyx in the Latin American markets.”
“This is a great step forward for Phenyx and GeneBio; we are very excited about
what this distribution deal will bring,” said Nasri Nahas, CEO of GeneBio. “GE
Healthcare’s reputation and distribution network are both first-class; this deal
allows us to take advantage of these factors and bring Phenyx to the fast
growing Latin American market in a very efficient manner. GeneBio has been
working with GEHC-LS since 2004 on Melanie’s distribution and we have
experienced a very professional and dynamic team that stays in close contact
with its clients and always endeavors to bring them the best for their research.
We look forward to continuing our long-term relationship with GEHC-LS and to the
successful expansion of our Phenyx business in Latin America.”
For more information concerning this distribution deal and for Phenyx product
demonstrations, please visit GeneBio booth #27 at the upcoming ASMS Conference
on Mass Spectrometry in Denver, Colorado, from June 1-5.
About GE Healthcare Life Sciences
GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our expertise in medical imaging and
information technologies, medical diagnostics, patient monitoring systems,
performance improvement, drug discovery, and biopharmaceutical manufacturing
technologies is helping clinicians around the world re-imagine new ways to
predict, diagnose, inform, treat and monitor disease, so patients can live their
lives to the fullest. GE Healthcare's broad range of products and services
enable healthcare providers to better diagnose and treat cancer, heart disease,
neurological diseases and other conditions earlier. Our vision for the future is
to enable a new "early health" model of care focused on earlier diagnosis,
pre-symptomatic disease detection and disease prevention. For more information
about GE Healthcare, visit our website at www.gehealthcare.com.
About GeneBio
Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company providing
the life science community with world-class proteomics software that bridges the
gap between information gathering and knowledge generation. Established in 1997,
GeneBio focuses its expertise on protein identification and characterization as
well as proteome imaging, offering clients and partners a high degree of
specialization essential to proteomics research. Close ties to academic peers
and a thorough network of distribution and strategic partners give the company
both unfettered access to scientific excellence and recognized market presence
so that we may best serve the scientific community. For more information about
GeneBio, please visit: www.genebio.com.
GE Healthcare Life Sciences contact:
Ms. Rosangela Oliveira
New Business Development Manager
rosangela.oliveira@ge.com
Tel. +55 11 3933 7300
GeneBio contact:
Mr. Andrew Smith
Marketing Manager
andrew.smith@genebio.com
Tel. +41 22 702 9900